|
|
| |
J.
John Mann M.D.
|
|
| |
J.
John Mann M.D., is trained in Psychiatry and
Internal Medicine. He has also obtained a doctorate
in
Neurochemistry. He is the Chief of the Department
of Neuroscience at the
New York State Psychiatric Institute and is Professor
of Psychiatry and Radiology at Columbia University.
His research employs functional brain imaging,
neurochemistry and molecular genetics to probe
the causes of depression and suicide. Dr. Mann
is the Director of the NIMH funded
Conte Center for the
Neuroscience
of Mental Disorders at Columbia University, Director
of the Stanley Center for Applied Neuroscience
of Bipolar Disorders, and President of the International
Academy of Suicide Research.
He has published 401 papers and edited 10 books
on the subjects
of the biology and treatment of mood disorders,
suicidal behavior and other psychiatric disorders.
In private practice he specializes in the treatment
of mood disorders. |
| |
Maria
A. Oquendo M.D.
|
|
| |
Maria
A. Oquendo, M.D. is Clinical Professor of Psychiatry
at Columbia
University, and is Director of the Clinical Evaluation
Core of the Conte Center for the Neurobiology
of Mental Disorders at the New York State Psychiatric
Institute, Department of Neuroscience. Her areas
of expertise include the diagnosis, pharmacologic
treatment and neurobiology of major depression,
and bipolar disorder, with a special focus on
suicidal behavior.
Dr. Oquendo graduated summa cum laude from Tufts
University and received her M.D. from the College
of Physicians and Surgeons at Columbia University
in 1984. She completed her residency in Psychiatry
at the Payne Whitney Psychiatric Clinic in the
New York Hospital-Cornell Medical Center.
Dr. Oquendo is the Principal Investigator on an
NIMH -funded high-risk study of suicide attempters
with bipolar disorder, on a prospective study of
suicidal
behavior
in patients with affective and psychotic disorders.
She is also a co-investigator on four other NIMH-funded
research studies examining the neurobiology of
suicidal behavior. She is the recipient of a grant
from the American Foundation for Suicide Prevention
for the study of serotonin transporter binding
using PET in bipolar suicide attempters, nonattempters
and healthy volunteers.
Dr. Oquendo also supervises residents and medical
students at Columbia University. She is a peer
reviewer for various psychiatric journals and grant
proposals submitted to the NIMH. Dr. Oquendo is
a member of the American Psychiatric Association,
the American Society of Hispanic Psychiatry, Group
for the Advancement of Psychiatry, Association
of Women Psychiatrists and the American Board of
Psychiatry and Neurology, on which she also functions
as an examiner. She is on the Scientific Advisory
Council of the American Foundation for Suicide
Prevention. She has authored or co-authored over
60 articles and chapters. She is the recipient
of several awards including Exemplary Psychiatrist
Award from the National Alliance for the Mentally
Ill (1993); Award from the National Alliance for
the Mentally Ill for Commitment to Multicultural
and Underserved Communities (2002); Travel Award
from American Foundation for Suicide Prevention
(2003); and the Marian Butterfield Early Career
Psychiatrist Award from the Association of Women
Psychiatrists (2004).
|
| |
Barbara
Stanley M.D.
|
photo to come |
| |
Barbara
Stanley, PhD, is a clinical psychologist and
Research
Scientist in the Department of Neuroscience at
the New York State Psychiatric Institute and
on the faculty of the Department of Psychiatry
at Columbia University. She has
conducted research on clinical factors, neurobiology,
and treatment of suicidal
behavior, self injury, borderline personality
disorder and depression. She is the recipient
of more than twenty years of continual funding
from the National Institute of Mental Health
and has also received grants from several private
foundations. Dr. Stanley is the President of
the American Foundation for Suicide Prevention
Metropolitan
New York Chapter and serves on its Scientific
Advisory Board. She also serves on the PRIM&R board,
a national research ethics organization, Personality
Disorders Foundation and TARA Association
for Personality Disorders. She has served on
several Institutional Review Boards and has been
a consultant for the NIH Office of Protection
from Research Risks. Dr. Stanley has also served
as a consultant to the NIMH in developing guidelines
for investigators who consider including suicidal
patients in treatment trials. Dr. Stanley has
published over 70 articles on suicidal behavior,
self-injury, borderline personality disorder,
depression, informed consent, competency and
research ethics. She is currently the Principal
Investigator on two NIMH-funded grants. One is
a psychosocial medication treatment trial for
actively suicidal and self-injuring individuals,
and the other looks at the neurobiological correlates
and clinical factors that distinguish suicide
attempters and non-attempters, as well as the
state and trait predictors of suicide attempts.
She also functions as Co-Investigator on two
other NIMH-funded research studies that examine
suicidal behavior.
|
|
| Page
tools |
|
email
this page |
|
|
print
this page |
|
|
| Sites
of Interest |
|
|
American
Foundation for Suicide Prevention |
|
|
International
Academy of Suicide Researchs |
|
|
National
Institute of Mental Health |
 |
Columbia
Depression Center |
| |
|
| |
|
|
|
|
| |
|
| |
|
|
